6
Oct
2026

Samsung Biologics

Exhibitor at CPHI Milan 2026 stand 6F68, Contract Manufacturing & Services
About Us

Samsung Biologics is an end-to-end CDMO partner of choice, providing highly tailored solutions to clients while meeting the evolving needs of the global healthcare industry.

With proven regulatory approvals, we provide seamless offerings from cell-line development to final fill/finish at every stage for biopharmaceutical products.

Our plants are cGMP compliant with a wide range of bioreactor scales. We are committed to maximizing operational efficiency and enhancing our development and manufacturing capabilities to meet growing market demand. Upon full completion of Plant 4 in the first half of 2023, we will hold a total capacity of 604KL at ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2018
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Primary activities
Contract Manufacturer
View company profile
Contact info
  • Website
  • 300 Songdo Bio Way (daero), Yeonsu-gu, 21987, Incheon, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 6F68, Contract Manufacturing & Services

Samsung Biologics Co., Ltd. Resources (1)